Blood Protein Discovered as Natural Shield Against Deadly Black Fungus

Breakthrough Discovery Reveals Hidden Defense Mechanism

Scientists have uncovered a remarkable natural defense mechanism hiding in plain sight within our bloodstream. Researchers at the Institute of Molecular Biology and Biotechnology and the University of Crete, working with international collaborators, discovered that albumin—the most abundant protein in human blood—acts as a master regulator in host defense against Mucorales fungi through modulation of fungal pathogenicity.

The groundbreaking study, published in Nature , reveals how this common blood protein serves as a selective shield against mucormycosis, a rare but often fatal infection also known as "black fungus." The disease occurs when spores of mucormycete fungi are inhaled or enter through wounds, secreting toxins that kill surrounding tissue and turn it black, sometimes within hours.

Clinical Evidence Points to Life-Saving Connection

The research team found that patients with mucormycosis have significantly lower albumin levels than those with other fungal diseases, with low albumin levels emerging as the strongest predictor of poor clinical outcomes across multiple continents. This discovery could revolutionize how doctors identify and treat patients at risk.

Laboratory studies demonstrated that albumin potently and selectively stops Mucorales growth among a broad range of human pathogens. When researchers removed albumin from blood samples of healthy individuals, mucormycetes grew unrestricted. Mouse studies confirmed this protective role—animals lacking albumin were specifically vulnerable to mucormycosis, while albumin administration restored disease resistance.

The Science Behind Nature's Shield

The protective mechanism works through free fatty acids bound to albumin, which the protein shields from oxidation. These fatty acids can then freely enter the fungus and prevent activation of genes essential for growth, while also blocking protein synthesis and suppressing production of key virulence factors.

Blood samples from mucormycosis patients showed increased oxidation of fatty acids, explaining their heightened susceptibility to infection. This mechanism may also explain why diabetes patients face higher mucormycosis risk—their albumin accumulates sugar residues, reducing its ability to bind and protect fatty acids from oxidation.

Implications for Future Treatment

The findings open new therapeutic avenues for albumin use in preventing and treating mucormycosis, a fatal disease with limited treatment options. These discoveries could help doctors spot the disease early, which is crucial since diagnosing mucormycosis can be difficult and any delay lowers survival chances, requiring doctors to "act really fast."

The research reveals a unique metabolic host defense mechanism that forces fungal pathogens to restrict their own growth in response to albumin-regulated signals, establishing a previously unknown role for this enigmatic protein in immune defense. As researchers continue exploring this natural shield, albumin may prove to be one of our most underappreciated defenders against life-threatening infections.